Digital Pathology Departments Will Prove Cost Effective
Making use of conventional light magnifying instrument has been typical practice for inspecting histopathology slides. However, the utilization of computerized pathology, which is also called as digital pathology, is on the ascent, and numerous pathology labs are currently putting resources into scanners for digitizing glass slides. As it is moves from simple to advanced workflows, numerous parts of their everyday work will be influenced. To a vast degree, these progressions reflect those that happened in radiology sections 10 to 15 years ago.
Digitalization of pathology does not aim at making computer perform the task pathologist, but to reduce time intensive work, which is otherwise difficult for normal human brain to function. Other advantages of it are a better production plan, permitting staff and supervisors to stay informed regarding what number of specimens are in the framework, where in the processing chain they are, is there a check on time limits etc.
Digital pathology is an emerging technology in the pathology field, where the glass slides are converted into digital images for easy viewing, analysis, storage and management of the data collected. The development and recent technological findings in this market would push the conventional pathology to more advanced and strategic levels. Due to the advancement in the technology, concerns such as lack of qualified pathologists would be addressed more effectively.
Hence, looking at the advantages of this concept, one may not be wrong to predict that digital pathology market is bright. As per allied market research, this is true. Allied Market Research states that digital pathology market provides a computer enabled image-based environment that allows analysis and management of pathology images. The global medical devices and diagnostics market is expected to attain market revenue of $362 billion by 2015. Globally, there is a rise in prevalence of chronic diseases, and digital pathology provides accurate monitoring of such diseases.
However, the cost of setting up such advanced lab is very high. To set up an all-inclusive digital pathology laboratory, a hospital may have to spend almost a million dollar. The high cost factor is a major restraint for the market growth. Another key challenge for the market players is to get approval for their products from concerned authorities such as U.S. Food & Drug Administration (FDA).
Some of the key players profiled in this report are 3DHistech, Ltd, Apollo Pacs, Inc., Corista, LLC, Hamamatsu Photonics K.K., Indica Labs, Inc., Ligolab, LLC, Nikon Instruments, Inc., Pathxl, Sunquest Information Systems and Visiopharm.
Digitalization of pathology does not aim at making computer perform the task pathologist, but to reduce time intensive work, which is otherwise difficult for normal human brain to function. Other advantages of it are a better production plan, permitting staff and supervisors to stay informed regarding what number of specimens are in the framework, where in the processing chain they are, is there a check on time limits etc.
Digital pathology is an emerging technology in the pathology field, where the glass slides are converted into digital images for easy viewing, analysis, storage and management of the data collected. The development and recent technological findings in this market would push the conventional pathology to more advanced and strategic levels. Due to the advancement in the technology, concerns such as lack of qualified pathologists would be addressed more effectively.
Hence, looking at the advantages of this concept, one may not be wrong to predict that digital pathology market is bright. As per allied market research, this is true. Allied Market Research states that digital pathology market provides a computer enabled image-based environment that allows analysis and management of pathology images. The global medical devices and diagnostics market is expected to attain market revenue of $362 billion by 2015. Globally, there is a rise in prevalence of chronic diseases, and digital pathology provides accurate monitoring of such diseases.
However, the cost of setting up such advanced lab is very high. To set up an all-inclusive digital pathology laboratory, a hospital may have to spend almost a million dollar. The high cost factor is a major restraint for the market growth. Another key challenge for the market players is to get approval for their products from concerned authorities such as U.S. Food & Drug Administration (FDA).
Some of the key players profiled in this report are 3DHistech, Ltd, Apollo Pacs, Inc., Corista, LLC, Hamamatsu Photonics K.K., Indica Labs, Inc., Ligolab, LLC, Nikon Instruments, Inc., Pathxl, Sunquest Information Systems and Visiopharm.
Source...